The 30th MedTech Investing Europe Conference

31 March & 1 April, 2020 The Hotel Royal Savoy • Lausanne • Switzerland

Bringing Together Innovators, Leading Investors and Major Healthcare Corporations

www.medtechinvesting.com

In Partnership with: Sponsored by:Organised by:

Who should attend The delegate profile is made up of the following individuals:

Investors with a core interest in healthcare.

Senior representatives from major healthcare corporations.

Venture-stage healthcare companies seeking financing.

Family offices and private investors.

Previous participants by country and sector Attracting over 140 delegates who at the last event represented 23 countries, the MTI conference is THE meeting place for break-through technologies and leading healthcare investors. In 2019 74% of the attendees purely focused on healthcare, with 26% investing in healthcare as part of a diverse investment portfolio.

Key statistics from MTI Lausanne 2019

146 Delegates

103 Companies

36 Presenting Companies Showcasing their Technologies

20 Speakers

23 Countries Represented

250+ Booked One-to-One Meetings

Investor Advisory BoardThe Investor Advisory Board is made up of some of the most pro-active investors in the sector. With a combined €31bn+ in AUM, they bring their wealth of experience and insight into the MTI series:

Senior Managing Director, OrbiMed, Israel

Partner, Siemens Venture Capital, USA

President, Sharfer Law Office, USA

Partner, Gilde Healthcare Partners, Netherlands

Partner, Apposite Capital, UK

CEO & Managing Partner, Ibionext, France

Founder & Managing Partner, Panakés Partners, Italy

About the event Now in its blockbuster 30th edition, The MedTech Investing Europe Conference offers a perfect combination of the latest investment opportunities in game-changing technologies and unrivalled programme content giving first-hand insight and opinion from senior-level healthcare investors and experts.

Pre-arranged One-To-One meetings and extensive networking opportunities will give investors and entrepreneurs ample opportunity to identify and meet with the companies and individuals that are right for you. This year’s agenda has been comprehensively researched and designed to cover the most up to date issues within this ever-developing sector and will provide delegates with the vital intelligence and advice needed to succeed in 2020 and beyond.

Consulting / Other VC / Private Equity /

Other Private Investors

Healthcare Corporate

Healthcare Presenting Company

Government / Academia / Industry

The MTI events have showcased over 1000 companies to our unrivalled audience of investors. Just some of the more recent include:

Benefits of attending Exclusive access to up to 30 pioneering healthcare innovators who will showcase their latest innovations and provide investors with a diverse range of opportunities for investment. The presentations will be streamed for the benefit of the audience and will include product information, stage of business, expected growth rates, exit strategy plans and the level of funding required.

Private one-to-one meetings with the innovators and investors of your choice to discuss potential business opportunities and foster future relationships. Last year over 250 meetings were pre-booked through our online networker, which will allow you to control your conference experience and make the most of your One-To-One meeting time by pre-arranging your twenty minute meetings with healthcare entrepreneurs and other industry leaders. You will also have the opportunity to access company profiles and be able to search by selecting the demographic of your choice.

Exclusive roundtable discussions and keynote presentations have been designed with industry experts to provide you with all the necessary information and guidance you need to flourish in today’s economic climate. Key sessions include:

The Investor Panel – Who are the investors driving the next wave of healthcare?

Commercialisation & How To Fund It – The path to becoming a world beating company.

Risk in Venture-Stage Healthcare – And how to successfully manage it.

Family Office & Private Wealth Investment in Healthcare.

The Future of Healthcare – Where is the healthcare heading?

Great peer-to-peer networking opportunities with leading investors, major healthcare corporations and technology companies who will all be reunited under one roof, offering a chance to discuss new business opportunities.

These companies are just an example of the type of ground-breaking investment opportunities available to investors at MTI Lausanne 2020. All the Presenting Companies and their details will be made available to registered delegates.

08:30 – 09:10 Registration, refreshments and networking

09:10 – 09:30 Welcome from the State of Vaud Raphael Conz, Economic Promotion Manager, Canton of Vaud, Switzerland

09.30 – 09:45 Chairman’s Opening Remarks

Welcoming-in the 30th anniversary MTI conference, our conference chairman explores just how healthy is the healthcare and life sciences industry today? What should be on the radar for investors and entrepreneurs? What impact are new and cutting edge technologies having on the sector, what is the future of regulations here in Europe and beyond and where are the opportunities for investors and entrepreneurs to succeed in a future world of healthcare?

Prof Benoît Dubuis, Executive Director, Campus Biotech & President, Inartis Foundation, Switzerland

09:45 – 10:30 The Investor Panel – Who are the investors driving the next wave of healthcare?

As investment trends shift and the sources of venture funding continue to evolve it is essential for both entrepreneurs and investors to understand who is funding the healthcare companies of tomorrow. What are their objectives, how can they help businesses grow and what are their exit horizons – these are all questions that need answers when fundraising or investing alongside other co-investors.

Family office, VC, corporate or angel? Where is venture-stage funding coming from today?

What else, beyond financial resources, can different investors bring?

How do investors choose what type of company to invest in?

What are the exit trends and are these the best for both founder and investor?

Daniel Bertholet, Private Investor & Founding Partner, 4See Ventures, SwitzerlandLionel Carnot, Partner, Earlybird Venture Capital, Germany

10:30 – 11:00 Fireside Chat with a Leading Business Builder

This is an opportunity to hear directly from a successful entrepreneur and investor who has developed a portfolio in healthcare. From setbacks and successes to where they see their next investment of development coming from, this session will provide an inspiration for all those in the room involved in highly innovative areas.

11:00 – 11:30 Morning coffee and networking opportunity

11:30 – 12:40 Healthcare companies pitch their investment opportunities

These sessions are dedicated to healthcare companies presenting innovative technology and investment opportunities in different sectors to an audience of investors. Each company will present for 10 minutes, in ONE of TWO Presentation Rooms.

CONFERENCE PROGRAMME – DAY ONETuesday 31 March, 2020

12:40 – 13:20 Commercialisation & How To Fund It – The path to becoming a world beating company

The one constant from an initial idea, through fundraising, business building and onto expansion is that of commercialisation. To attract both funding entrepreneurs must demonstrate both the theoretical usefulness of their innovation and its likelihood to grow and occupy a meaningful position in the market. What financial support for scaling is available, how can initial sales projections be made more credible, and what market penetration schemes are favoured in today’s healthcare market environment?

Just how important is a robust and solid commercialisation plan?

What role do investors play in getting products to market?

When is the right time to expand internationally to take advantage of new markets?

Incremental innovation or completely new tech – what does the market actually want?

Samuel M. Shafner, President, Shafner Law Office, USA

13:20 – 14:20 Lunch and networking opportunity

14:20 – 15:30 Healthcare companies pitch their investment opportunities

These sessions are dedicated to Healthcare companies presenting innovative technology and investment opportunities in different sectors to an audience of investors. Each company will present for 10 minutes, in ONE of TWO Presentation Rooms.

15:30 – 16:00 Risk in Venture-Stage Healthcare – And how to successfully manage it

Risk is nothing new for growing healthcare companies and managing it is an essential part of a company’s successful development. From regulatory hurdles, to manufacturing challenges, to “will the technology really perform as it should?” – what should investors look out for and how is the wider macro-environment affecting companies today?

What is the investor risk appetite in the market today? Does this change between investors?

The importance of building a strong team and inter-personal relationships in minimising risk.

Are regulatory requirements always barriers to a technology’s development?

How does investment risk change as companies move to later rounds of investment?

Jonathan Goldstein, Director, Corporate R&D and Venture, Boston Scientific, IsraelDr Joachim Rautter, Managing Partner, Peppermint Venture Partners GmbH, Germany

16:00 – 16:30 Afternoon coffee and networking opportunity

16:30 – 17:50 One-To-One Meetings: Special pre-scheduled individual One-To-One meetings will be taking place in our dedicated meeting area. This session will consist of 4 x 20min One-To-One meetings.

END OF DAY ONE

18:00 – 19:00 Networking Drinks Reception

This will be an informal reception allowing you to network with all attendees, building and extending valuable networks.

08:30 – 09:30 Registration, breakfast refreshments and informal networking

09.30 – 09:40 Chairman’s Opening Remarks

What were the learnings from day one and what can we see on the second day of the conference?

Prof Benoît Dubuis, Executive Director, Campus Biotech & President, Inartis Foundation, Switzerland

09:40 – 10:30 Family Office & Private Wealth Investment in Healthcare

Family offices and private investors have in recent years come to the fore as a preferred investor option, now bringing a professional approach and benefits far beyond just financial resources. But this private and discreet group can be hard to reach so how can they be identified and what do they really bring to the investments they make? How do they operate and wat are their ultimate goals?

Are family offices impulsive or careful and considered investors?

Why is co-investment amongst families and private investors often important?

How can entrepreneurs identify, approach and secure funding from this elusive group?

How have family offices professionalised their approach and what are they looking for?Chee Yang Chen, Family Member, Crossbow Capital, Singapore/UKAlexander Felman, Director, Felman Family Office, Denmark

10:30 – 11:00 The Role of the Healthcare Corporation in Venture-Stage Development

With more major healthcare corporations putting the development of innovation at the heart of their growth strategies, their role in supporting and developing innovation and venture stage companies is a fundamental one in moving the sector forward. What are major organisations looking for from venture-stage companies and what can these global players themselves bring?

11:00 – 11:30 Morning coffee and networking opportunity

11:30 – 12:40 Healthcare companies pitch their investment opportunities

These sessions are dedicated to Healthcare companies presenting innovative technology and investment opportunities in different sectors to an audience of investors. Each company will present for 10 minutes, in ONE of TWO Presentation Room.

12:40 – 13:40 Lunch and networking opportunity

CONFERENCE PROGRAMME – DAY TWOWednesday 1 April, 2020

13:40 – 14:30 Healthcare companies pitch their investment opportunities

The broad healthcare sector is constantly evolving, from the regulatory landscape to cutting-edge tech changing the face of healthcare delivery. This evolution is essential to meet head-on the demands of an ever-increasing global population and new and complex healthcare challenges. What does the future of the healthcare sector have in store and how will entrepreneurs and investors have to adapt?

Where will funding be coming from and how will this affect development of new tech?

How can early-stage companies differentiate themselves from the crowd?

What does MDR and the new regulatory environment in Europe mean for development?

How is cutting-edge tech such as AI, big data & digital health impacting traditional healthcare?Imran Hamid, Senior Director, New Ventures & Transactions, Johnson & Johnson Innovation, UK

14:30 – 14:40 Chairman’s Closing Remarks

As the 30th MedTech Investing Europe Conference draws to a close what are the trends that we are seeing from both leading investors and cutting edge technology companies? Disruption, technology, global expansion, sector sophistication and ultimately healthcare requirements all continues apace – what are the key takeaways for investors and entrepreneurs alike?

Prof Benoît Dubuis, Executive Director, Campus Biotech & President, Inartis Foundation, Switzerland

14:40 – 14:50 Best in Show Presenting Company Awards

Voted for by the audience and attendees, these awards recognise the Presenting Companies who offer the most exciting, ground-breaking and disruptive technologies accompanied by the management teams and business models that will enable these winning companies to continue to grow into world-beating organisations.

14:50 – 16:30 One-To-One Meetings: Special pre-scheduled individual One-To-One meetings will be taking place in our dedicated meeting area. This session will consist of 5 x 20min One-To-One meetings.

For delegates wishing to hold additional ad hoc meetings, designated meeting space will be available at the venue beyond the official close of the conference.

16:45 End of conference

“It was a great opportunity for us to connect with European companieswe have not met yet and expand our global investment portfolio.

Kazuki Sakamoto, Associate Manager, Teijin Limited, Japan

MTI Europe is in my view a ‘must-attend’ event for anyone involved in building medical device startups. It significantly contributes to the effort of fostering

a much-needed ecosystem of startups, executives, VCs, corporates and service providers in the European MedTech space.

Aris Constantinides, Investment Director, NBGI Ventures, UK

The conference was well run and interesting, and I enjoyed attending.

The number and range of Presenting Companies -and their investment opportunities was superb.

Carlos Pittol, Director, Clubb Capital, UK

The organisation of the event was impeccable, the atmosphere was professional and relaxed, and the quality of participant was extremely high.

Malcolm Dermit, Executive Director, Swiss Life Private Placement Life Insurance, Switzerland

“

“

”

”

”

Feedback from previous MedTech Investing Europe events:

“ ”

The 30th MedTech Investing Europe Conference

Scan the QR code for the latest MTI updates

@MTI_Europe#MTI20

Ticket Options

Early Bird Discount: £999 / €1400 book before 31st January 2020 Standard Price: £1495 / €2095 from 1st February 2020

Corporate Ticket “3 for the price of 2”: £2990 / €4100Non-Qualifying Investor Ticket: £2000 / €2800

20% VAT will be added where applicable

How to RegisterVisit www.medtechinvesting.com and click on ‘Book Now’

Email: blanca.morales@campdenwealth.comCall: +44 (0)20 3763 2800

Interested in becoming a Presenting Company?Present your investment opportunity to an audience of private investors, venture capital and private equity partners and blue-chip corporations.

For more information on Presenting Company opportunities please contact:Anthony Hackett on +44 (0)20 3763 2800, email: anthonyhackett@campdenwealth.com

30 Cannon Street, Lower Ground Floor, London, EC24M 6XH, UKTel: +44 (0)20 3763 2800

www.medtechinvesting.com

Organised by: